| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/30/1996 | US5541077 Fungal stress proteins |
| 07/30/1996 | US5541071 Assay for identifying antagonists of gastrin and CCK-B receptors |
| 07/30/1996 | US5541068 Isolated and purified polypeptide encoded by messenger rna used to detect susceptibility of obesity |
| 07/30/1996 | US5541065 Amplifying nucleic acid sequence from exon two of human leukocyte antigen dpbeta gene in sample, mixing with panel of sequence specific oligonucleotide probes, detecting hybrids formed, determining genotype |
| 07/30/1996 | US5541063 Human interleukin-3 receptor α subunit |
| 07/30/1996 | US5540933 Isolation and use of fibronectin receptor |
| 07/30/1996 | US5540926 Gp39 protein |
| 07/30/1996 | US5540925 Anticarcinogenic, antitumor agents; bioactivity in vitro against human pancreatic and lung carcinoma cells |
| 07/30/1996 | US5540923 Antiviral, antitumor, from trophoblast cells |
| 07/30/1996 | US5540908 Detection of hypoxia with reagents containing 2-nitroimidazole compounds and methods of making such reagents |
| 07/30/1996 | CA1338501C Method of detecting antibody against htlv-iii |
| 07/25/1996 | WO1996022390A1 Methods, polypeptides, nucleotide sequence of xor-6, a vitamin d-like receptor from xenopus |
| 07/25/1996 | WO1996022386A1 A method for screening for inhibition of periplasmic oxidoreductase enzymes |
| 07/25/1996 | WO1996022383A1 Spectroscopically detectable nucleic acid ligands |
| 07/25/1996 | WO1996022379A2 Direct gene transfer into the ruminant mammary gland |
| 07/25/1996 | WO1996022378A1 Cells for the production of recombinant adenoviruses |
| 07/25/1996 | WO1996022377A1 Activation of t-cells by modified, antigenic immunoglobulins |
| 07/25/1996 | WO1996022375A2 Procedures and materials for conferring disease resistance in plants |
| 07/25/1996 | WO1996022374A1 A new chemokine expressed in fetal spleen, its production and uses |
| 07/25/1996 | WO1996022373A2 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma |
| 07/25/1996 | WO1996022372A2 Antibodies for the control of cyst nematodes and transgenic plants expressing them |
| 07/25/1996 | WO1996022371A2 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2 |
| 07/25/1996 | WO1996022370A1 Human fas gene promoter region |
| 07/25/1996 | WO1996022369A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 07/25/1996 | WO1996022363A1 Recombinant swinepox virus |
| 07/25/1996 | WO1996022361A1 GENE ENCODING AN INVERTEBRATE α1CALCIUM CHANNEL SUBUNIT |
| 07/25/1996 | WO1996022308A2 Appetite suppression factor and related methods |
| 07/25/1996 | WO1996022307A1 Genes encoding an insect calcium channel |
| 07/25/1996 | WO1996022306A1 Novel peptide |
| 07/25/1996 | WO1996022304A1 Conformationally constrained reverse-turn library and methods relating thereto |
| 07/25/1996 | WO1996022303A1 Therapeutic compound - fatty acid conjugates |
| 07/25/1996 | WO1996022301A1 HETEROLOGOUS POLYPEPTIDE PRODUCTION IN THE ABSENCE OF NONSENSE-MEDIATED mRNA DECAY FUNCTION |
| 07/25/1996 | WO1996022106A1 Cd8 antagonists |
| 07/25/1996 | WO1996022067A2 Peptide ratchet libraries for ctl-inducing vaccines and therapeutics |
| 07/25/1996 | WO1996022016A1 Transgenic plants and plant cells with enhanced pathogen resistance and related methods |
| 07/25/1996 | WO1996012021A3 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 07/25/1996 | WO1996006177A3 Retrovirus-like particles made non-infectious by a plurality of mutations |
| 07/25/1996 | CA2241977A1 Antibodies for the control of cyst nematodes and transgenic plants expressing them |
| 07/25/1996 | CA2210997A1 Activation of t-cells by modified, antigenic immunoglobulins |
| 07/25/1996 | CA2210897A1 Direct gene transfer into the ruminant mammary gland |
| 07/25/1996 | CA2210679A1 Methods, polypeptides, nucleotide sequence of xor-6, a vitamin d-like receptor from xenopus |
| 07/25/1996 | CA2210560A1 Heterologous polypeptide production in the absence of nonsense-mediated mrna decay function |
| 07/25/1996 | CA2210521A1 Transgenic plants and plant cells with enhanced pathogen resistance and related methods |
| 07/25/1996 | CA2210500A1 Therapeutic compound - fatty acid conjugates |
| 07/25/1996 | CA2210440A1 Procedures and materials for conferring disease resistance in plants |
| 07/25/1996 | CA2210349A1 Conformationally constrained reverse-turn library and methods relating thereto |
| 07/25/1996 | CA2210168A1 Cells for the production of recombinant adenoviruses |
| 07/25/1996 | CA2210158A1 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma |
| 07/25/1996 | CA2207086A1 G protein-coupled receptor gene |
| 07/25/1996 | CA2207009A1 A new chemokine expressed in fetal spleen, its production and uses |
| 07/24/1996 | EP0723016A2 Activating factor of leukocytes |
| 07/24/1996 | EP0723015A1 Novel modified PF4 compositions and methods of use |
| 07/24/1996 | EP0723014A2 cDNA of DOCK180 gene and DOCK180 protein |
| 07/24/1996 | EP0723013A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/24/1996 | EP0722951A2 Method and apparatus for the production of TGF-beta and purified TGF-beta compositions |
| 07/24/1996 | EP0722738A2 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations |
| 07/24/1996 | EP0722737A1 Remedy for cranial nerve disorder |
| 07/24/1996 | EP0722735A1 Parathyroid hypertensive factor |
| 07/24/1996 | EP0722501A1 Cloned pullulanase |
| 07/24/1996 | EP0722499A1 Immunoreactive antigens of hepatitis e virus |
| 07/24/1996 | EP0722498A1 Virus resistant or tolerant cells |
| 07/24/1996 | EP0722496A1 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 07/24/1996 | EP0722495A1 A method for displaying proteins |
| 07/24/1996 | EP0722489A1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| 07/24/1996 | EP0722463A1 Methods and composition for the modulation of host immune response to allergens |
| 07/24/1996 | EP0722462A1 Dna encoding prostaglandin receptor ip |
| 07/24/1996 | EP0722461A1 Expression of fusion polypeptides transported out of the cytoplasm without leader sequences |
| 07/24/1996 | EP0722460A1 Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
| 07/24/1996 | EP0722452A1 Nf-at polypeptides and polynucleotides |
| 07/24/1996 | EP0722343A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 07/24/1996 | EP0722339A1 $i(VIBRIO CHOLERAE) 01 (CVD111) AND NON-01 (CVD112 AND CVD112RM) SEROGROUP VACCINE STRAINS AND METHODS OF MAKING SAME |
| 07/24/1996 | EP0722337A1 Cd8?+ cell antiviral factor |
| 07/24/1996 | EP0722334A1 Therapeutic treatment for inhibiting blood vessel blockage using a polypeptide |
| 07/24/1996 | EP0722333A1 Method of treating depressed reticuloendothelial system function |
| 07/24/1996 | EP0722329A1 Alpha 1?-acid glycoprotein purification process and product |
| 07/24/1996 | EP0722318A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 07/24/1996 | EP0722275A1 Cell death regulator |
| 07/24/1996 | EP0665850A4 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions. |
| 07/24/1996 | EP0612250B1 Methods and compositions relating to useful antigens of moraxella catarrhalis |
| 07/24/1996 | EP0560968B1 Vaccine for neisseria meningitidis infections |
| 07/24/1996 | EP0555336B1 Homobifunctional agents for coupling enzymes and the like to antibodies and the like |
| 07/24/1996 | EP0466901B1 Dna segments and transformed microorganisms comprising the gene of delta-1 -dehydrogenase, and uses thereof |
| 07/24/1996 | EP0396612B1 Novel plasmid vector with pectate lyase signal sequence |
| 07/24/1996 | CN1127532A Method for diagnosing a disorder by determining expression of GAGE tumor rejection antigen precursors |
| 07/24/1996 | CN1127529A Agonists and antagonists of human interleukin-10 |
| 07/24/1996 | CN1127528A Modified alpha-lactalbumin |
| 07/24/1996 | CN1127299A Process for purifying recombinant human serum albumin |
| 07/24/1996 | CN1127260A Purification process for hirudin using affinity chromatography |
| 07/24/1996 | CN1127259A Peptides |
| 07/24/1996 | CA2167858A1 Sequence of af1q cdna |
| 07/24/1996 | CA2167763A1 Mercaptoalkyldipeptide derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 07/24/1996 | CA2140814A1 Use of calreticulin in modulating hormone responsiveness and new pharmaceuticals for treating cancer, osteoporosis and chronic inflammatory disease |
| 07/23/1996 | US5539104 1,4 Diazocines as fibrinogen antagonists |
| 07/23/1996 | US5539096 Genes differentially expressed in metastatic and non-metastatic rat rhabdomyosarcoma cell lines |
| 07/23/1996 | US5539094 DNA encoding Bcl-2-associated proteins |
| 07/23/1996 | US5539087 Antibiotic A/16686 recovery process |
| 07/23/1996 | US5539086 Therapeutic fragments of von Willebrand factor |
| 07/23/1996 | US5539085 Polypeptide complex, screening for agents which inhibit certain cancers, agents which modulate cell growth |
| 07/23/1996 | US5539084 Separation of a specific binding entity for a mixture |
| 07/23/1996 | US5539083 Peptide nucleic acid combinatorial libraries and improved methods of synthesis |